Literature DB >> 11519

Possible association of schizophrenia with a disturbance in prostaglandin metabolism: a physiological hypothesis.

W Feldberg.   

Abstract

Schizophrenia may be associated with increased prostaglandin synthesis in certain parts of the brain. This hypothesis is based on the following findings: (1) Catalepsy, which is the nearest equivalent in animals to human catatonia, develops in cats when prostaglandin E1 is injected into the cerebral ventricles and when during endotoxin or lipid A fever the prostaglandin E2 level in cisternal c.s.f. rises to high levels; however, when fever and prostaglandin level are brought down by non-steroid anti-pyretics which inhibit prostaglandin synthesis, catalepsy disappears as well. (2) Febrile episodes are a genuine syndrome of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 11519     DOI: 10.1017/s0033291700015798

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  6 in total

Review 1.  Platelets: A possible glance into brain biological processes in schizophrenia.

Authors:  Eyal Asor; Dorit Ben-Shachar
Journal:  World J Psychiatry       Date:  2012-12-22

2.  Semantic memory in schizophrenia: association with cell membrane essential fatty acids.

Authors:  Ruth Condray; Jeffrey K Yao; Stuart R Steinhauer; Daniel P van Kammen; Ravinder D Reddy; Lisa A Morrow
Journal:  Schizophr Res       Date:  2008-10-16       Impact factor: 4.939

3.  Elevated plasma prostaglandin E2 levels in schizophrenia.

Authors:  H Kaiya; M Uematsu; M Ofuji; A Nishida; K Takeuchi; M Nozaki; E Idaka
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients.

Authors:  K S Vaddadi; C J Gilleard; R H Mindham; R Butler
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Decreased 16:0/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia.

Authors:  Junya Matsumoto; Hiroki Nakanishi; Yasuto Kunii; Yuki Sugiura; Dai Yuki; Akira Wada; Mizuki Hino; Shin-Ichi Niwa; Takeshi Kondo; Michihiko Waki; Takahiro Hayasaka; Noritaka Masaki; Hiroyasu Akatsu; Yoshio Hashizume; Sakon Yamamoto; Shinji Sato; Takehiko Sasaki; Mitsutoshi Setou; Hirooki Yabe
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

6.  Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Somaye Arabzadeh; Atefeh Zeinoddini; Seyed-Ali Mostafavi; Mehdi Hamedi; Abolfazl Ehyaii; Ali Ghaleiha; Arefeh Zeinoddini; Shahin Akhondzadeh
Journal:  Iran J Psychiatry       Date:  2018-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.